News
LVTX
1.740
0.00%
0.000
Weekly Report: what happened at LVTX last week (1117-1121)?
Weekly Report · 11/24 09:01
LAVA Therapeutics Delists from Nasdaq and Changes Leadership
TipRanks · 11/21 13:31
LAVA Therapeutics Announces Voluntary Delisting from Nasdaq
Reuters · 11/21 13:01
XOMA Royalty Closes Acquisition of LAVA Therapeutics
Reuters · 11/21 12:45
NASDAQ TRADE HALT <LVTX.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 11/21 00:50
Weekly Report: what happened at LVTX last week (1110-1114)?
Weekly Report · 11/17 09:01
LAVA Therapeutics to Delist from Nasdaq Amid Acquisition
TipRanks · 11/13 14:03
LAVA intents to delist from Nasdaq
Seeking Alpha · 11/13 13:51
Lava Therapeutics announces intent to delist from Nasdaq
TipRanks · 11/13 12:45
LAVA THERAPEUTICS NV - SUBMITS NOTICE TO NASDAQ TO VOLUNTARILY DELIST SHARES
Reuters · 11/13 12:30
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq
Barchart · 11/13 06:30
BiotechBroyalty aggregator XOMA reports Q3 net income of $14.1 mln
Reuters · 11/12 12:41
REFILE-Biotech royalty aggregator XOMA reports Q3 net income of $14.1 mln
Reuters · 11/12 12:41
XOMA Royalty reports Q3 revenue of $9.4 million and year-to-date revenue of $38.4 million
Reuters · 11/12 12:30
LAVA Therapeutics Extends Share Tender Deadline for XOMA Offer to November 12, 2025
Reuters · 11/10 21:14
Weekly Report: what happened at LVTX last week (1103-1107)?
Weekly Report · 11/10 09:01
LAVA Therapeutics Approves Merger with New Topco B.V.
TipRanks · 11/07 21:33
LAVA Therapeutics NV Held Extraordinary General Meeting
Reuters · 11/07 21:09
Weekly Report: what happened at LVTX last week (1027-1031)?
Weekly Report · 11/03 09:01
Weekly Report: what happened at LVTX last week (1020-1024)?
Weekly Report · 10/27 09:01
More
Webull provides a variety of real-time LVTX stock news. You can receive the latest news about LAVA Therapeutics N.V. through multiple platforms. This information may help you make smarter investment decisions.
About LVTX
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.